There are also some reports of WGS being successfully used to implicate rare, high-penetrance germline variants in cancer, for example POT1 mutations in familial melanoma [39] and POLE and POLD1 mutations in colorectal adenomas and carcinomas [40]. This evidence concerns the gene POLD1 and carcinoma.